Tawi, Romelyn .
HRN: 22-40-07 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/31/2022
MUPIROCIN 2%, 15G (TUBE)
12/31/2022
01/05/2023
TOPICAL OU
Thinly
Bid
Skin Infection
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes